Fda form 3794-2026

Get Form
fda form 3794 Preview on Page 1

Here's how it works

01. Edit your fda form 3794 online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send form 3794 via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out FDA Form 3794 with our platform

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2
  1. Click ‘Get Form’ to open FDA Form 3794 in the editor.
  2. Begin by filling out the 'Applicant, Holder or Owner' section. Enter the legal name and address of the entity that owns or controls the submission.
  3. In the 'Representative or U.S. Agent' field, provide contact details for a person authorized to respond to inquiries regarding this cover sheet.
  4. Indicate the applicable fiscal year for your payment, which runs from October 1 to September 30.
  5. Select the type of generic drug user fee by checking the appropriate box under 'Generic Drug User Fee Type'.
  6. For ANDA submissions, enter the six-digit application number. Ensure you include leading zeroes if necessary.
  7. Complete all relevant sections regarding API manufacturing information and facility details as required.

Start using our platform today to streamline your form completion process for free!

See more fda form 3794 versions

We've got more versions of the fda form 3794 form. Select the right fda form 3794 version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2013 4.8 Satisfied (118 Votes)
2012 4.4 Satisfied (346 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The document outlines Form FDA 3454, a financial disclosure certification for clinical investigators as required by 21 CFR Part 54, which mandates the reporting of financial interests that may bias clinical study outcomes.
Under the GDUFA II framework, correspondence seeking regulatory and/or scientific advice after issuance of a Complete Response Letter or tentative approval, or after ANDA approval, was considered general correspondence. Under GDUFA III, these types of correspondence can be submitted as controlled correspondence.
Also known as a notice of inspection, the Food and Drug Administration (FDA) Form 482 is an official document presented to the investigator upon arrival at the study site that gives the FDA the authority to access, inspect and copy any required records related to the clinical investigation.
Form FDA 2656 This form is used by all drug firms both domestic and foreign who are required to register and drug list products with the Food and Drug Administration. This form is also used to provide updates in registration information annually or at the discretion of the registrant, when any changes occur.

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance
be ready to get more

Complete this form in 5 minutes or less

Get form